Learn About Pineocytoma

What is the definition of Pineocytoma?
A Pineocytoma is a tumor of the pineal gland, a small organ in the brain that makes melatonin (a sleep-regulating hormone). Signs and symptoms of Pineocytomas include headaches, nausea, hydrocephalus, vision abnormalities, and Parinaud syndrome. Pineocytomas are usually slow-growing and rarely spread to other parts of the body.
What are the alternative names for Pineocytoma?
  • Pineocytoma
  • Pinealocytoma
  • Pinealoma
Who are the top Pineocytoma Local Doctors?
Elite in Pineocytoma
Radiation Oncology
Elite in Pineocytoma
Radiation Oncology

University Of California San Francisco

400 Parnassus Ave, Mcb300, 
San Francisco, CA 
Languages Spoken:
English
Offers Telehealth

David Raleigh is a Radiation Oncologist in San Francisco, California. Dr. Raleigh is rated as an Elite provider by MediFind in the treatment of Pineocytoma. His top areas of expertise are Meningioma, Pineocytoma, Brain Tumor, and Gliomatosis Cerebri.

Elite in Pineocytoma
Elite in Pineocytoma
Helsinki, FI 

Joham Velasquez-Choque practices in Helsinki, Finland. Velasquez-Choque is rated as an Elite expert by MediFind in the treatment of Pineocytoma. Their top areas of expertise are Pineocytoma, Vein of Galen Aneurysm, Brain Tumor, Nerve Decompression, and Extracranial-Intracranial Bypass Surgery.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pineocytoma
Elite in Pineocytoma
Groupement Hospitalier Est, 
Bron, FR 

Carmine Mottolese practices in Bron, France. Mr. Mottolese is rated as an Elite expert by MediFind in the treatment of Pineocytoma. His top areas of expertise are Pineocytoma, Plagiocephaly, Metopic Ridge, Craniectomy, and Awake Craniotomy.

What are the latest Pineocytoma Clinical Trials?
Phase I Clinical Trial of GPC2 Chimeric Antigen Receptor T (GPC2-CAR T) Cells for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Summary: This is a single-site, open-label Phase 1 clinical trial evaluating the feasibility, safety, and preliminary activity of autologous GPC2-targeted chimeric antigen receptor (CAR) T cells administered via intracerebroventricular (ICV) infusion in children and young adults with relapsed or refractory medulloblastoma or other eligible Central Nervous System (CNS) embryonal tumors.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Summary: The primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the maximum-tolerated dose) and evaluate the occurrence of dose-limiting toxicities (DLTs) following single weekly or multiple-day weekly dose regimens of single-agent, oral ONC206 in patients with recurrent, primary central nervous system (CNS) ne...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Pineocytoma?
Pineal parenchymal tumor in a domestic rabbit.
Tired of the same old research?
Check Latest Advances